Converting Problems into Opportunities When Building Up a Biobank
Add bookmark
Pharma IQ is joined by Mark Divers, Executive Director, KI Biobank at Karolinska Institute, to discuss some of the prevalent aspects in the growing field of biobanking, from international partnerships to standardising protocol. [inlinead]
